Hepatitis Monthly

Published by: Kowsar

Type of Pegylated Interferon Matters: Another Milestone in the Treatment of Hepatitis C Virus Infection

Ashwani Kumar Singal 1 , *
Author Information
1 Division of Gastroenterology, Department of Internal Medicine, University of Texas Medical Branch, aksingal@utmb.edu, Texas, USA
Article information
  • Hepatitis Monthly: , 10 (3); 165-167
  • Article Type: Editorial
  • Received: October 25, 2009
  • Accepted: May 9, 2010

To Cite: Singal A. Type of Pegylated Interferon Matters: Another Milestone in the Treatment of Hepatitis C Virus Infection, Hepat Mon. Online ahead of Print ;10(3):165-167.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments